当硅谷的创新脉搏与全球医疗健康的发展浪潮共振，一场聚焦生物医药与医疗器械领域的盛会即将启幕！在JP Morgan会议期间，元禾控股将携手BioBAY及全球顶尖合作伙伴，于旧金山重磅打造高规格闭门峰会，以“聚势JP Morgan・链接苏州”为主题，搭建苏州与全球生物医药创新生态的高效链接桥梁。

本次峰会汇聚全球顶级力量：元禾控股及其合作机构携雄厚资源入局；Johnson&Johnson、Gilead、BI等跨国药企带来BD合作需求，更有中国生物医药创新领袖齐聚一堂。这不仅是一场洞察行业趋势的思想盛宴，更是一个依托JP Morgan生态，链接全球资源，实现资本与项目精准对接、技术与市场高效匹配、国内创新与全球视野深度融合的交流平台。

作为国内生物医药产业投资的 “领航者”，多年来，元禾控股凭借对行业趋势的精准判断与长期主义的投资理念，构建了 “资本赋能+产业孵化+生态协同” 的全链条服务体系，为初创企业提供资金支持、技术对接、产业链资源整合等全方位保障，助力企业快速成长为行业标杆。累计投资生物医药企业超350家次，培育出信达生物、亚盛药业、映恩生物等行业领军企业，成功推动18家生物医药企业在境内外上市，助力超30款创新药成功上市惠及全球患者。在当前的出海热潮下，多个元禾的被投企业完成产品对外授权交易，总交易金额超过415亿美元，交易对手不乏大型跨国药企，成为国内生物医药投资领域的中坚力量。

聚全球之势，启创新征程！期待与您在硅谷相遇，共绘生物医药产业发展新蓝图！

一、会议信息：

会议时间：2026年1月14日（周三）14:00-19:00（美西时间）

会议地点：JJ Lake Business Center 340 E Middlefield Rd, Mountain View, CA 94043

主办机构：元禾控股、BioBAY

二、会议日程：

14:00-14:30 签到

开启生物医药午后思想盛宴。

14:30-14:40 致辞

-BioBAY：孵化全球竞争力的生物医药产业园

-元禾控股：穿越周期的耐心资本

14:40-17:00 项目路演

代表性中国创新企业，集中发布最前沿技术突破与临床进展。

17:00-19:00 交流晚宴

与演讲CEO、国际投资人、产业伙伴深度自由对接，促成实质性合作。

无论您是怀揣创业愿景的专家学者、深耕赛道的创业先锋，还是领航产业的行业领袖、精准布局的资深投资人，都诚邀您报名参会，或提交优质项目参与现场路演！

Gathering Momentum at JP Morgan · Linking to Suzhou——ORIZA Holdings & BioBAY Global Biopharmaceutical Closed-Door Summit Invites You to Forge the Future of Innovation

When Silicon Valley's innovative pulse resonates with the global wave of healthcare development, a premier gathering focused on the biopharmaceutical and medical device sectors is about to commence! During the JP Morgan Conference, ORIZA Holdings will join hands with BioBAY and top-tier global partners to host a high-profile closed-door summit in San Francisco. Under the theme "Gathering Momentum at JP Morgan •  Linking to Suzhou" the summit aims to build an efficient bridge linking Suzhou with the global biopharmaceutical innovation ecosystem.

This summit brings together global top-tier forces: ORIZA Holdings and its partner institutions are joining with substantial resources; multinational pharmaceutical giants like Johnson & Johnson, Gilead, and Boehringer Ingelheim bring BD collaboration opportunities. This is not only an intellectual feast for industry trend insights but also a communication platform leveraging the JP Morgan ecosystem to connect global resources. It facilitates precise capital-project matchmaking, efficient technology-market alignment, and deep integration of domestic innovation with global perspectives.

As a domestic "vanguard" in biopharmaceutical industry investment, ORIZA Holdings has, over the years, built a full-chain service system of "capital empowerment, industry incubation, and ecosystem collaboration" through its accurate judgment of industry trends and long-term investment philosophy. The system provides comprehensive support for startups, including funding, technology partnerships, and industrial chain resource integration, helping them rapidly grow into industry benchmarks. To date, ORIZA Holdings has invested in over 350 biopharmaceutical companies, nurturing sector leaders such as Innovent Biologics, Ascentage Pharma, and Duality Biologics. It has successfully facilitated the listing of 18 biopharmaceutical companies domestically and internationally and supported the launch of over 30 innovative drugs, benefiting patients worldwide. Amid the current wave of globalization, several ORIZA portfolio companies have completed out-licensing deals totaling over $41.5 billion, with transaction counterparts including large multinational pharmaceutical firms, solidifying ORIZA Holdings's role as a cornerstone in China's biopharmaceutical investment landscape.

Gathering global momentum, we embark on an innovative journey! We look forward to meeting you in Silicon Valley to jointly chart a new blueprint for biopharmaceutical industry development.

I. About the Summit

Time: January 14, 2026 (Wednesday), 14:00–19:00 (Pacific Time)

Location: JJ Lake Business Center 340 E Middlefield Rd, Mountain View, CA 94043

Co-host: ORIZA Holdings & BioBAY

II. Agenda

◆14:00–14:30 | Check-in

Starting an afternoon of insights into biomedicine.

◆14:30–14:40 | Speeches

- BioBAY: A Biomedicine Park Fostering Global Competitiveness

- ORIZA Holdings: Patient capital Through the Whole Growth Cycle

◆14:40–17:00 | Project roadshow

Leading Chinese companies unveil their latest technological breakthroughs and clinical progress.

◆17:00–19:00 | Networking dinner

Deep, free dialogues with CEOs, international investors, and industry partners to drive substantive collaborations.

Whether you are a visionary scholar-entrepreneur, a trailblazing pioneer in the field, an industry-leading expert, or an experienced investor with strategic insights, we cordially invite you to register for the summit or submit high-quality projects for on-site roadshows!

返回列表